JB
Jamil Beg
Venture Capitalist & Bioentrepreneur
JB
Jamil Beg
Venture Capitalist & Bioentrepreneur
Cambridge, Massachusetts
Overview
Work Experience
Partner
2024 - Current
Founding Investor
2020
Clinical stage, small molecule company developing inhaled therapeutics for respiratory diseases
Board of Directors
2020
Founding Investor
2022
Stealth stage genetic renal disease company
Chief Executive Officer
2022 - 2023
Founder
2018
Clinical stage, precision neuroscience company developing small molecules to transform the lives of patients suffering from neurological diseases
Board of Directors
2018 - 2023
Chief Executive Officer
2018 - 2021
Partner
2017 - 2023
5AM Ventures is an early stage life science venture fund focused on company creation and investments in seed and Series A companies
Guest Lecturer
2019 - 2022
Board Observer
2018 - 2021
Clinical stage company developing transformative breakthrough therapies for patients with severe and rare disorders (IPO in July 2021)
Board Member
2007 - 2021
Mentor
2017 - 2021
Board Observer
2017 - 2020
Clinical stage, gene therapy company developing treatments for inner ear disorders (IPO in June 2020; acquired by Eli Lilly in October 2022)